Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
- 511 Downloads
Studies investigating the association between aspirin use and gastric cancer risk have reported conflicting results. The objective of this study was to quantitatively summarize the evidence for such a relationship.
Two investigators independently searched the Medline, PubMed, Embase, and Academic Search Premier (EBSCO) databases. Fourteen studies with a total number of 5,640 gastric cancer cases were identified. Most of the study populations were Caucasian. The combined results based on all studies showed there was no statistically significant difference between aspirin use and gastric cancer risk (odds ratio (OR) = 0.80, 95% confidence intervals (CI) = 0.54–1.19). When stratifying by study designs and gender, results were similar except for cohort and randomized controlled trial (RCT) studies (OR = 0.72, 95% CI = 0.62–0.84). When stratifying by location and Helicobacter pylori (H. pylori) infection, we observed there were lower risks in noncardia gastric cancer (OR = 0.62, 95% CI = 0.55–0.69) and H. pylori-infected individuals (OR = 0.62, 95% CI = 0.42–0.90) for aspirin users. Among Caucasians, there were lower risks for noncardia gastric cancer (OR = 0.73, 95% CI = 0.62–0.87) and H. pylori-infected individuals (OR = 0.62, 95% CI = 0.42–0.90) also.
This meta-analysis indicated that regular use of aspirin may be associated with reduced risk of noncardia gastric cancer, especially among Caucasians; for H. pylori-infected subjects the result was similar.
KeywordsAspirin Gastric cancer Helicobacter pylori Meta-analysis
Conflict of Interest Statement
We declare that no conflict of interest exists for any of the authors.
- 6.Tong Q, Wang G, Lu X, Tao K, Chen D. Expression and clinical significance of nuclear factor-kB and cyclooxygenase-2 in gastric carcinoma tissue. Chin J Gastroenterol. 2006;11:160–163.Google Scholar
- 7.Hou L, Grillo P, Zhu ZZ, et al. COX-1 and COX-2 polymorphisms and gastric cancer risk in a Polish population. Anticancer Res. 2007;27:4234–4247.Google Scholar
- 17.Jonge PJF, Wolters LMM, Steyerberg EW, et al. Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in Dutch cohort. Aliment Pharmacol Ther. 2007;26:31–39.Google Scholar
- 18.Giliies M, Skyring A. Gastric ulcer, duodenal ulcer and gastric carcinoma: a case-control study of certain social and environmental factors. Med J Aust. 1968;2:1132–1136.Google Scholar
- 21.Farrow DC, Vaughan TL, Hansten PD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomark Prev. 1998;7:97–102.Google Scholar
- 31.Figueroa JD, Terry MB, Gammon MD, et al. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. Cancer Causes Control. 2009;20:361–368.CrossRefPubMedGoogle Scholar
- 41.Tatemichi M, Sasazuki S, Inoue M, Tsugane S. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nest case-control study using IgG titer against Hp surface antigen. Acta Oncol. 2008;47:360–365.CrossRefPubMedGoogle Scholar
- 44.Takahashi M, Katayama Y, Takada H, Kuwayama H, Terano A. The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts. Aliment Pharmacol Ther. 2004;14(Suppl 1):44–49.Google Scholar
- 46.Patterson RE, Neuhouser ML, White E, Hunt JR, Kristal AR. Cancer-related behavior of vitamin supplement users. Cancer Epidemiol Biomark Prev. 1998;7:79–81.Google Scholar
- 47.Sample DA, Sinicrope PS, Wargovich MJ, Sinicrope FA. Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial. Cancer Epidemiol Biomark Prev. 2002;11:281–285.Google Scholar
- 48.Ryár I, Hlísta M, Masark P, et al. Gastroduodenal complication associated with non-steroidal anti-inflammatory drugs in Slovak Republic: result of one-year prospective study. Vnitr Lek. 2006;52:673–676.Google Scholar